Inositol Treatment and ART Outcomes in Women with PCOS
Polycystic ovary syndrome (PCOS) affects 5–10% of women in reproductive age and is characterized by oligo/amenorrhea, androgen excess, insulin resistance, and typical polycystic ovarian morphology. It is the most common cause of infertility secondary to ovulatory dysfunction. The underlying etiology...
Saved in:
| Main Authors: | Deepika Garg, Reshef Tal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2016/1979654 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myo-Inositol in the Treatment of Teenagers Affected by PCOS
by: Lali Pkhaladze, et al.
Published: (2016-01-01) -
Inositol Treatment for PCOS Should Be Science-Based and Not Arbitrary
by: Scott Roseff, et al.
Published: (2020-01-01) -
Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols
by: Antonio Simone Laganà, et al.
Published: (2016-01-01) -
PCOS and Inositols – Advances and Lessons We are Learning. A Narrative Review
by: Lentini G, et al.
Published: (2025-05-01) -
Antioxidant and cytokine modulation in PCOS rats protected with probiotics, myo-inositol, and herbal extracts
by: AA Zaki, et al.
Published: (2025-06-01)